e-learning
resources
London 2016
Monday, 05.09.2016
Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Treatment outcomes of macrolide-resistant mycobacterium avium complex lung disease
Seong Mi Moon (Seoul, Republic of Korea), Seong Mi Moon, Hye Yun Park, Su-Young Kim, Kyeongman Jeon, Seung-Heon Lee, Chang Ki Kim, Sung Jae Shin, Won-Jung Koh
Source:
International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections
Session:
Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections
Session type:
Thematic Poster
Number:
2567
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Seong Mi Moon (Seoul, Republic of Korea), Seong Mi Moon, Hye Yun Park, Su-Young Kim, Kyeongman Jeon, Seung-Heon Lee, Chang Ki Kim, Sung Jae Shin, Won-Jung Koh. Treatment outcomes of macrolide-resistant mycobacterium avium complex lung disease. Eur Respir J 2016; 48: Suppl. 60, 2567
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Retrospective observation of
mycobacterium avium
complex lung disease followed without treatment
Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management
Year: 2013
Efficacy and safety of kanamycin addition in patients with drug-refractory mycobacterium avium complex lung disease
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical and functional characterisation
Year: 2015
Development of a prognostic scoring system for Mycobacterium avium complex lung disease
Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections
Year: 2016
Isolation of
M. abscessus
from patients with
M. avium
complex (MAC) lung disease
Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections
Year: 2013
Treatment of refractory
mycobacterium avium
complex lung disease with a moxifloxacin-containing regimen
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013
LATE-BREAKING ABSTRACT: Genotyping
mycobacterium avium
has a clinical potential to predict therapeutic responses of the lung infection
Source: Annual Congress 2013 –Research questions on how viruses affect the respiratory system
Year: 2013
Retrospective investigation of patients positive for glycopeptidolipid-core antibody to mycobacterium avium complex pulmonary disease
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014
Characteristics of patients with isolation of mycobacterium xenopi
Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management
Year: 2013
Outcomes of
Mycobacterium avium
complex lung disease based on clinical phenotype
Source: Eur Respir J, 50 (3) 1602503; 10.1183/13993003.02503-2016
Year: 2017
Clinical characteristics and treatment outcomes of patients with macrolide-resistant Mycobacterium avium complex pulmonary disease: a systemic review and meta-analysis
Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection
Year: 2019
Clinical and laboratory features of Mycobacterium avium complex infection in comparison with infection, caused by Mycobacterium tuberculosis, in HIV-infected patients
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II
Year: 2019
Factors related to response to intermittent treatment of
mycobacterium avium
complex lung disease
Source: Eur Respir J 2006; 28: Suppl. 50, 557s
Year: 2006
Susceptibility to nontuberculous mycobacterial lung disease
Source: Eur Respir J 2008; 31: 1322-1333
Year: 2008
Clinical analysis of pulmonary Mycobacterium avium complex disease in Japan
Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings
Year: 2012
Paradoxical response during antibiotic treatment in patients with Mycobacterium avium complex lung disease
Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis
Year: 2020
Clinical relevance of Mycobacterium simiae in pulmonary samples
Source: Eur Respir J 2008; 31: 106-109
Year: 2008
Management of
Mycobacterium avium
complex and
Mycobacterium abscessus
pulmonary disease: therapeutic advances and emerging treatments
Source: Eur Respir Rev, 31 (163) 210212; 10.1183/16000617.0212-2021
Year: 2022
Risk factors for Mycobacterium tuberculosis infection among contacts of pulmonary tuberculosis patients
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I
Year: 2012
Association between injectable aminoglycoside treatment duration and outcomes in cavitary Mycobacterium avium complex lung disease
Source: International Congress 2018 – Challenges in treating tuberculosis and nontuberculous mycobacteria
Year: 2018
Nontuberculous mycobacterial lung disease caused by
Mycobacterium parascrofulaceum
in an immunocompetent patient
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept